ChoA Pharmaceutical Co.Ltd (034940) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ChoA Pharmaceutical Co.Ltd (034940) has a cash flow conversion efficiency ratio of -0.016x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-505.40 Million ≈ $-342.50K USD) by net assets (₩32.06 Billion ≈ $21.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 034940 stock market capitalisation for the company's overall valuation and market capitalisation.
ChoA Pharmaceutical Co.Ltd - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how ChoA Pharmaceutical Co.Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
ChoA Pharmaceutical Co.Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ChoA Pharmaceutical Co.Ltd ranked by their cash flow conversion efficiency. Explore 034940 cash to earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Miliboo SA
PA:ALMLB
|
0.126x |
|
Edinburgh Worldwide Investment Trust plc
LSE:EWI
|
-0.013x |
|
Pinnacle Food Group Limited Class A Common Shares
NASDAQ:PFAI
|
N/A |
|
Advanced Packaging Tech (Malaysia)
KLSE:9148
|
-0.030x |
|
Grup Serban Holding
RO:GSH
|
N/A |
|
Prairie Provident Resources Inc
TO:PPR
|
0.100x |
|
AFRICAN PIONEER PLC O.N.
F:9TI
|
N/A |
|
Canaf Investments Inc
V:CAF
|
0.002x |
Annual Cash Flow Conversion Efficiency for ChoA Pharmaceutical Co.Ltd (2004–2025)
The table below shows the annual cash flow conversion efficiency of ChoA Pharmaceutical Co.Ltd from 2004 to 2025. View 034940 stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩21.77 Billion ≈ $14.75 Million |
₩-4.18 Billion ≈ $-2.83 Million |
-0.192x | -34.84% |
| 2024-12-31 | ₩31.38 Billion ≈ $21.26 Million |
₩-4.47 Billion ≈ $-3.03 Million |
-0.142x | -274.13% |
| 2023-12-31 | ₩38.76 Billion ≈ $26.27 Million |
₩-1.48 Billion ≈ $-999.75K |
-0.038x | -39.39% |
| 2022-12-31 | ₩52.84 Billion ≈ $35.81 Million |
₩-1.44 Billion ≈ $-977.89K |
-0.027x | +7.92% |
| 2021-12-31 | ₩49.92 Billion ≈ $33.83 Million |
₩-1.48 Billion ≈ $-1.00 Million |
-0.030x | -189.97% |
| 2020-12-31 | ₩58.30 Billion ≈ $39.51 Million |
₩1.92 Billion ≈ $1.30 Million |
0.033x | -57.93% |
| 2019-12-31 | ₩53.06 Billion ≈ $35.96 Million |
₩4.16 Billion ≈ $2.82 Million |
0.078x | +106.82% |
| 2018-12-31 | ₩53.96 Billion ≈ $36.57 Million |
₩2.04 Billion ≈ $1.39 Million |
0.038x | +403.82% |
| 2017-12-31 | ₩54.18 Billion ≈ $36.71 Million |
₩-675.51 Million ≈ $-457.78K |
-0.012x | -164.11% |
| 2016-12-31 | ₩47.84 Billion ≈ $32.42 Million |
₩930.42 Million ≈ $630.53K |
0.019x | -22.74% |
| 2015-12-31 | ₩47.15 Billion ≈ $31.96 Million |
₩1.19 Billion ≈ $804.48K |
0.025x | +85.49% |
| 2014-12-31 | ₩46.09 Billion ≈ $31.23 Million |
₩625.52 Million ≈ $423.90K |
0.014x | -80.55% |
| 2013-12-31 | ₩50.63 Billion ≈ $34.31 Million |
₩3.53 Billion ≈ $2.39 Million |
0.070x | -68.88% |
| 2004-12-31 | ₩15.94 Billion ≈ $10.81 Million |
₩3.57 Billion ≈ $2.42 Million |
0.224x | -- |
About ChoA Pharmaceutical Co.Ltd
ChoA Pharmaceutical Co., Ltd. operates as a pharmaceutical company in South Korea. The company produces approximately 200 medicines and health foods, including 30 internal ampoule products, such as Hepos, Fematin, Vasoclean, Mabis, etc. Its products include drugs for digestive, circulatory, and respiratory systems; vitamins, minerals, and nutrients; anti inflammation and analgesics; peripheral ne… Read more